研究文章
临床结果从没有“真实世界”长冠状动脉病变患者接受40毫米可生物降解聚合物涂层支架析
|
|
在医院(;100%) |
30天随访(;100%) |
6个月随访(;99.22%) |
|
| 死亡,(%) |
2 (0.8%) |
2 (0.8%) |
2 (0.8%) |
| 心脏死亡,(%) |
2 (0.8%) |
2 (0.8%) |
2 (0.8%) |
| 非心血管死亡,(%) |
0 (0%) |
0 (0%) |
0 (0%) |
| 心肌梗塞,(%) |
0 (0%) |
0 (0%) |
3 (1.2%) |
| q波性,(%) |
0 (0%) |
0 (0%) |
2 (0.8%) |
| Non-Q-wave,(%) |
0 (0%) |
0 (0%) |
1 (0.4%) |
| TLR,(%) |
0 (0%) |
0 (0%) |
0 (0%) |
| TVR,(%) |
0 (0%) |
0 (0%) |
0 (0%) |
| 圣,(%) |
0 (0%) |
0 (0%) |
0 (0%) |
| 总 |
2 (0.8%) |
2 (0.8%) |
5 (2.0%) |
|
|
TVR:目标血管血管再生;TLR:靶病变血管再生;圣:支架血栓形成。
|